176 related articles for article (PubMed ID: 28714564)
1. Laryngeal distribution of recurrent respiratory papillomatosis in a previously untreated cohort.
Benedict PA; Ruiz R; Yoo M; Verma A; Ahmed OH; Wang B; Dion GR; Voigt A; Merati A; Rosen CA; Amin MR; Branski RC
Laryngoscope; 2018 Jan; 128(1):138-143. PubMed ID: 28714564
[TBL] [Abstract][Full Text] [Related]
2. Laryngeal distribution of adult-onset recurrent respiratory papillomatosis: A longitudinal study.
Hu L; Benedict PA; Garber D; Wang B; Amin MR; Branski RC
Laryngoscope; 2019 Sep; 129(9):1993-1997. PubMed ID: 31059600
[TBL] [Abstract][Full Text] [Related]
3. Prospective, Multi-Center Study of the Anatomic Distribution of Recurrent Respiratory Papillomatosis.
Benedict PA; Kravietz A; Achlatis E; Wang B; Zhang Y; Kidane J; Harrison T; Miller J; Drake VE; Best SR; McWhorter AJ; Lin RJ; Rosen CA; Smith LJ; Amin MR
Laryngoscope; 2022 Dec; 132(12):2403-2411. PubMed ID: 35129220
[TBL] [Abstract][Full Text] [Related]
4. Is recurrent respiratory papillomatosis a manageable or curable disease?
Kim HT; Baizhumanova AS
Laryngoscope; 2016 Jun; 126(6):1359-64. PubMed ID: 26608928
[TBL] [Abstract][Full Text] [Related]
5. Risk Factors for Dysplasia in Recurrent Respiratory Papillomatosis in an Adult and Pediatric Population.
Karatayli-Ozgursoy S; Bishop JA; Hillel A; Akst L; Best SR
Ann Otol Rhinol Laryngol; 2016 Mar; 125(3):235-41. PubMed ID: 26453486
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of diabetes mellitus and its impact on disease severity in adult recurrent respiratory papillomatosis.
Lee CJ; Allen CT; Merati AL
Otolaryngol Head Neck Surg; 2013 Oct; 149(4):603-7. PubMed ID: 23851281
[TBL] [Abstract][Full Text] [Related]
7. Safety and clinical activity of PD-L1 blockade in patients with aggressive recurrent respiratory papillomatosis.
Allen CT; Lee S; Norberg SM; Kovalovsky D; Ye H; Clavijo PE; Hu-Lieskovan S; Schlegel R; Schlom J; Strauss J; Gulley JL; Trepel J; Hinrichs CS
J Immunother Cancer; 2019 May; 7(1):119. PubMed ID: 31053174
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of Systemic Bevacizumab for Recurrent Respiratory Papillomatosis with Pulmonary Involvement.
So RJ; Hidalgo Lopez JC; Ballestas SA; Klein AM; Steuer C; Shin DM; Abousaud M; Teng Y; Saba NF; Tkaczuk AT; Schaefer ES; Seiwert TY; McClellan K; Best SR
Laryngoscope; 2024 Feb; 134(2):577-581. PubMed ID: 37470254
[TBL] [Abstract][Full Text] [Related]
9. A Novel In Vivo Model of Laryngeal Papillomavirus-Associated Disease Using
King RE; Bilger A; Rademacher J; Ward-Shaw ET; Hu R; Lambert PF; Thibeault SL
Viruses; 2022 May; 14(5):. PubMed ID: 35632742
[TBL] [Abstract][Full Text] [Related]
10. Narrow band imaging is a new technique in visualization of recurrent respiratory papillomatosis.
Tjon Pian Gi RE; Halmos GB; van Hemel BM; van den Heuvel ER; van der Laan BF; Plaat BE; Dikkers FG
Laryngoscope; 2012 Aug; 122(8):1826-30. PubMed ID: 22566012
[TBL] [Abstract][Full Text] [Related]
11. Factors Associated with Iatrogenic Laryngeal Injury in Recurrent Respiratory Papillomatosis.
So RJ; Hillel AT; Motz KM; Akst LM; Best SR
Otolaryngol Head Neck Surg; 2024 Apr; 170(4):1091-1098. PubMed ID: 38123898
[TBL] [Abstract][Full Text] [Related]
12. Juvenile recurrent respiratory papillomatosis: 10-year audit and Australian prevalence estimates.
Novakovic D; Cheng AT; Baguley K; Walker P; Harrison H; Soma M; Malloy M; Brotherton JM
Laryngoscope; 2016 Dec; 126(12):2827-2832. PubMed ID: 27074766
[TBL] [Abstract][Full Text] [Related]
13. Recurrent laryngeal papillomatosis: multimodal therapeutic strategies. Literature review and multicentre retrospective study.
Bertino G; Pedretti F; Mauramati S; Filauro M; Vallin A; Mora F; Crosetti E; Succo G; Peretti G; Benazzo M
Acta Otorhinolaryngol Ital; 2023 Apr; 43(Suppl. 1):S111-S122. PubMed ID: 37698108
[TBL] [Abstract][Full Text] [Related]
14. Anatomic Derkay Score Is Associated with Voice Handicap in Laryngeal Papillomatosis in Adults.
Kupfer RA; Çadalli Tatar E; Barry JO; Allen CT; Merati AL
Otolaryngol Head Neck Surg; 2016 Apr; 154(4):689-92. PubMed ID: 26908550
[TBL] [Abstract][Full Text] [Related]
15. Serum matrix metalloproteinase 8 and tissue inhibitor of metalloproteinase 1: Potential markers for malignant transformation of recurrent respiratory papillomatosis and for prognosis of laryngeal cancer.
Pakkanen PP; Aaltonen LM; Sorsa TA; Tervahartiala TI; Hagström JK; Ilmarinen TT
Head Neck; 2019 Feb; 41(2):309-314. PubMed ID: 30549356
[TBL] [Abstract][Full Text] [Related]
16. Multidimensional vocal assessment after laser treatment for recurrent respiratory papillomatosis.
Kono T; Yabe H; Uno K; Saito K; Ogawa K
Laryngoscope; 2017 Mar; 127(3):679-684. PubMed ID: 27515839
[TBL] [Abstract][Full Text] [Related]
17. Office-Based vs Traditional Operating Room Management of Recurrent Respiratory Papillomatosis: Impact of Patient Characteristics and Disease Severity.
Tatar EÇ; Kupfer RA; Barry JY; Allen CT; Merati AL
JAMA Otolaryngol Head Neck Surg; 2017 Jan; 143(1):55-59. PubMed ID: 27658005
[TBL] [Abstract][Full Text] [Related]
18. Laryngeal reconstruction in children with recurrent respiratory papillomatosis.
Scatolini ML; Cocciaglia A; Pérez CG; Rodríguez HA
Int J Pediatr Otorhinolaryngol; 2018 Dec; 115():120-124. PubMed ID: 30368371
[TBL] [Abstract][Full Text] [Related]
19. The predominant site of pharyngeal lesions in patients with recurrent respiratory papillomatosis.
Matsuzaki H; Asai R; Makiyama K
Eur Arch Otorhinolaryngol; 2022 Sep; 279(9):4461-4464. PubMed ID: 35503132
[TBL] [Abstract][Full Text] [Related]
20. Laryngopharyngeal reflux and herpes simplex virus type 2 are possible risk factors for adult-onset recurrent respiratory papillomatosis (prospective case-control study).
Formánek M; Jančatová D; Komínek P; Matoušek P; Zeleník K
Clin Otolaryngol; 2017 Jun; 42(3):597-601. PubMed ID: 27759910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
